To assess the relationship between frequency of cannabis use and sleep duration across age in a large US population (235,667 people).
Multinomial logistic regression was used to evaluate the association between the frequency of cannabis use and sleep duration using cross sectional data from the 2016-2018 Behavioral Risk Factor Surveillance System.
When adjusted for sociodemographic factors, health related variables, and stratified by age we found that young adults (18-44 years) who reported daily-use (≥16 uses a month) had an increased risk ratio (RR [95% CI]) for either short or long sleep (1.22 [1.06-1.40] and 1.52 [1.07-2.16]); midlife adults (45-64 years) who reported daily-use had an increased prevalence of long sleep (1.71 [1.03-2.82]); and older adults (≥65 years) who reported daily-use had an increased prevalence of short sleep (1.61 [1.05-2.49]).
Compared to those who reported no cannabis use, individuals who reported daily cannabis use demonstrated a greater prevalence for either short or long sleep duration.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Sleep Health: Journal of the National Sleep Foundation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Cannabis use and sleep: expectations, outcomes, and the role of age.Addict Behav. 2021; 112106642https://doi.org/10.1016/j.addbeh.2020.106642
- Decreasing perceived risk associated with regular cannabis use among older adults in the United States from 2015 to 2019.J Am Geriatr Soc. 2021; 69: 2591-2597
- Perceived risk of harm from monthly cannabis use among US adolescents: National Survey on drug Use and Health, 2017.Prev Med Rep. 2021; 23101436https://doi.org/10.1016/j.pmedr.2021.101436
- Trends and correlates of marijuana use among late middle-aged and older adults in the United States, 2002–2014.Drug Alcohol Depend. 2017; 171: 97-106
- Monitoring the Future National Survey Results on Drug Use, 1975-2020. Volume II. Institute for Social Research, Ann Arbor2021 (College Students & Adults Ages 19-60)
- Cannabis use patterns and motives: a comparison of younger, middle-aged, and older medical cannabis dispensary patients.Addict Behav. 2017; 72: 14-20https://doi.org/10.1016/j.addbeh.2017.03.006
- Sleep and its disorders in aging populations.Sleep Med. 2009; 10 (PubMed PMID: 19647483): S7-11https://doi.org/10.1016/j.sleep.2009.07.004
- Efficacy and safety of medical cannabinoids in older subjects: a systematic review.Ageing Res Rev. 2014; 14 (PubMed PMID: 24509411): 56-64https://doi.org/10.1016/j.arr.2014.01.007
- Recommended amount of sleep for a healthy adult: a joint consensus statement of the american academy of sleep medicine and sleep research society.Sleep. 2015; 38 (PubMed PMID: 26039963; PubMed Central PMCID: PMC4434546): 843-844https://doi.org/10.5665/sleep.4716
- Recent cannabis use and nightly sleep duration in adults: a population analysis of the NHANES from 2005 to 2018.Reg Anesth Pain Med. 2022; 47: 100-104
- Trends in Cannabis use among older adults in the United States, 2015-2018.JAMA Intern Med. 2020; 180: 609-611https://doi.org/10.1001/jamainternmed.2019.7517
- Association of sleep duration in middle and old age with incidence of dementia.Nature Communications. 2021; 12: 1-10
- Medical cannabis use: exploring the perceptions and experiences of older adults with chronic conditions.Clin Gerontol. 2021; 44: 32-41
- Sleep patterns and insomnia in a large population-based study of middle-aged and older adults: the Tromsø study 2015-2016.J Sleep Res. 2021; 30 (Epub 20200529. PubMed PMID: 32469116): e13095https://doi.org/10.1111/jsr.13095
- Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies.Sleep Med Rev. 2020; 53101339https://doi.org/10.1016/j.smrv.2020.101339
- Sleep Disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation.Biol Psychiatry. 2016; 80: 40-52https://doi.org/10.1016/j.biopsych.2015.05.014
- Self-reported sleep duration and quality and cardiovascular disease and mortality: a dose-response meta-analysis.J Am Heart Assoc. 2018; 7e008552https://doi.org/10.1161/JAHA.118.008552
- Association of sleep duration with all-cause and disease-specific mortality in US adults.J Epidemiol Community Health. 2021; 75: 556-561
- Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies.Eur Heart J. 2011; 32: 1484-1492
- Marijuana use patterns and sleep among community-based young adults.J Addict Dis. 2016; 35 (Epub 20160104. PubMed PMID: 26727193; PubMed Central PMCID: PMC4911998): 135-143https://doi.org/10.1080/10550887.2015.1132986
- Cannabinoids in the treatment of insomnia disorder: a systematic review and meta-analysis.CNS drugs. 2020; 34: 1217-1228
- Cannabis, cannabinoids, and sleep: a review of the literature.Curr Psychiatry Rep. 2017; 19: 23https://doi.org/10.1007/s11920-017-0775-9
- Recent legalization of cannabis use: effects on sleep, health, and workplace safety.Nat Sci Sleep. 2017; 9: 249
- Insufficient and excessive amounts of sleep increase the risk of premature death from cardiovascular and other diseases: the multiethnic cohort study.Prev Med. 2013; 57 (PubMed PMID: 23811525; PubMed Central PMCID: PMC3947517): 377-385https://doi.org/10.1016/j.ypmed.2013.06.017
Published online: November 17, 2022
Accepted: October 14, 2022
Received in revised form: September 29, 2022
Received: June 16, 2022
Publication stageIn Press Corrected Proof
© 2022 National Sleep Foundation. Published by Elsevier Inc. All rights reserved.